Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors-Reference-Cited by-同舟云学术

Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors

Published:1992-08 Issue:4 Volume:106 Page:1028-1034
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Boer Jacob,Philpott Alison J.,Amsterdam Ronald G.M.,Shahid Mohammed,Zaagsma Johan,Nicholson C. David

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.1992.tb14451.x/fullpdf

Reference35 articles.

1. Primary sequence of cyclic nucleotide phosphodiesterase isoenzymes and the design of selective inhibitors;BEAVO;Trends Pharmacol. Sci,1990

2. Partial purification of cyclic nucleotide phosphodiesterases from human bronchial tissue;BERGSTRAND;Mol. Cell. Biochem,1978

3. Phosphodiesterase inhibition in isolated ventricular myocytes and multicellular ventricular preparations from guinea-pig hearts;BETHKE;Naunyn-Schmiedebergs Arch. Pharmacol,1991

4. Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue;BODE;Circ. Res,1991

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials);American Journal of Respiratory and Critical Care Medicine;2023-08-15

2. Ensifentrine as a Novel, Inhaled Treatment for Patients with COPD;International Journal of Chronic Obstructive Pulmonary Disease;2023-07

3. Effects of Extracts and Flavonoids from Drosera rotundifolia L. on Ciliary Beat Frequency and Murine Airway Smooth Muscle;Molecules;2022-10-05

4. A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy;International Journal of Chronic Obstructive Pulmonary Disease;2021-04

5. Clinical Relevance of the Anti-inflammatory Effects of Roflumilast on Human Bronchus: Potentiation by a Long-Acting Beta-2-Agonist;Frontiers in Pharmacology;2020-12-08